Mounjaro side effects and pregnancy: the guidance every woman should read

Why the guidance says no, and what the evidence actually shows

The short answer is that no one knows how tirzepatide affects a developing baby in humans, because pregnant women were excluded from the clinical trials. What researchers do have is data from animal studies, and those studies found reduced foetal weight, skeletal abnormalities and increased pregnancy loss at doses that overlap with the therapeutic range used in people. That is enough for the Mounjaro prescribing information, and for the NHS, to advise clearly against use in pregnancy.

The NHS medicines page for tirzepatide states that Mounjaro should not be taken during pregnancy. This is not a precautionary footnote buried in small print, it sits prominently in the guidance because the consequences of getting this wrong could be serious. If you are pregnant and have been taking Mounjaro, our page on whether Mounjaro is safe in pregnancy explains what the current evidence says and why stopping promptly and speaking to your midwife or GP is the right next step.

Tirzepatide also has a half-life of roughly five days, meaning it clears your system more slowly than a daily tablet would. That pharmacokinetic detail matters when thinking about timing around conception, your prescriber can advise on how long a wash-out period is appropriate before trying to conceive.

Breastfeeding and trying to conceive: the same caution applies

The not-recommended guidance extends beyond pregnancy itself. It covers breastfeeding too: it is not known whether tirzepatide passes into breast milk in humans, and the potential for harm to a nursing infant means the medicine should be stopped before breastfeeding begins.

For women who are planning to become pregnant, the recommendation is to stop Mounjaro before attempting conception and allow an adequate wash-out period. The prescribing information does not specify a precise interval, which is one reason a conversation with your GP or a specialist (rather than a general online answer) matters here. Stopping treatment also needs to be weighed against the health risks of obesity during pregnancy, which are themselves significant: that balance is genuinely individual and deserves a careful clinical discussion, not a blanket rule applied without context.

If you want a fuller picture of the available evidence on tirzepatide before and during pregnancy, our page on Mounjaro and pregnancy risk goes into more depth on what the animal data show and what they do and do not tell us about human risk.

Contraception while on Mounjaro: a practical point many people miss

There is an important practical issue that often catches people off guard. Because tirzepatide slows gastric emptying, it can reduce how well the oral contraceptive pill is absorbed. The NHS advises that women taking oral contraceptives should use an additional, non-oral contraceptive method (condoms are the most practical) for the first four weeks after starting Mounjaro and for four weeks after each dose increase. NHS England's guidance on weight-management injections addresses this directly.

If your contraceptive pill is kept in the fridge door next to other morning-routine items, it is worth pausing to check whether your current contraceptive method needs reviewing before you begin or increase tirzepatide. A simple conversation with your GP or pharmacist sorts this out quickly. The same absorption concern applies to HRT taken as a tablet, NHS England advises considering transdermal patches or gels during treatment, and your doctor can advise on what is right for you.

This is not a reason to avoid Mounjaro if you are not planning a pregnancy, but it is a reason to sort out contraception properly before you start. Our prescribers discuss this as part of every clinical consultation.

What to do if your situation is more complex

Some women face a genuinely difficult picture: they have been taking Mounjaro for weight management, their obesity itself carries pregnancy risks, and they are now wondering whether to continue, pause or stop. There is no single correct answer that applies to everyone in that position.

What the guidance does make clear is that continuing Mounjaro through pregnancy is not the right path on current evidence. Stopping it is. The harder question (how to manage weight-related health risks during pregnancy without tirzepatide) is one for your obstetric team, GP or specialist, who can look at your complete medical picture. Our page on whether Mounjaro is safe for pregnant women explores this balance in more detail, including what specialists typically consider when reviewing individual cases.

If you have further questions about how Mounjaro works and its general side-effect profile, our full Mounjaro side effects page covers the broader picture. And if you are considering starting Mounjaro for weight management and pregnancy is not currently a factor, you can learn more about the treatment through our Mounjaro overview or speak to our prescribers by starting a free consultation, a real clinician reviews every case the same day.

If you have any concerns or questions after reading this, our team is also reachable through our contact page. For broader questions about weight management options, including whether tirzepatide is safe during pregnancy, our treatment overview is a useful starting point.